Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Reconstitution to Cytomegalovirus After Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Clinical Factors and Therapy Strategies

NCT05656599 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05656599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05656599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Reconstitution to Cytomegalovirus After Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Clinical Factors and Therapy Strategies
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 3, 2023
Completion date
December 31, 2025
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cmv infection, hematopoietic stem cell transplantation